Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Multiscale modeling for cancer radiotherapies

Fig. 4

Survival curves for different human cell lines: adenocarcinomic A549 cells (a), normal fibroblasts AG1522 (b), cervical cancer HeLa cells (c), normal skin fibroblasts NB1RGB (d), glioblastoma A172 cell line (e), and endothelial EAhy926 cells (f). The calculated survival probabilities are shown with lines and experimental data from Wéra et al. (2011, 2013) (A549), Raju (1991), Autsavapromporn (2011), Hamada (2006) (AG1522), Zhao (2013), Usami (2016) (HeLa), Tsuruoka (2005), Suzuki (2000) (NB1RGB), Suzuki (2000), Tsuboi (1998) (A172), and Riquier (2013) (EAhy926) are shown with symbols

Back to article page